Compounding pharmacy recalls six IV lots over endotoxin contamination after adverse reactions

Centric Compounding has recalled six lots of intravenous medications used in wellness and immunity treatments after nine reports of fever, chills, chest pain, and other symptoms, indicating possible endotoxin contamination. The recall is precautionary; the source of contamination and full scope of exposure remain under investigation. This matters as contaminated IV products pose direct patient safety risks and may trigger regulatory scrutiny of compounding practices.